3,* * Based on 95,334 patients with or without type 2 diabetes (T2DM) who filed a prescription for GLP-1based treatment (tirzepatide, semaglutide, or liraglutide) between 2010 and 2023 for any indication
Indeed, it has been suggested that agents capable of achieving an average weight reduction of about 15% in individuals with obesity represent a new generation of anti-obesity medications, as this level of weight loss is sufficient to combat or prevent a broader range of obesity-related complications (238)
Antioxidant Support: By neutralizing free radicalsunstable molecules that damage cellsit reduces the oxidative stress that often triggers the skin to produce more pigment as a protective response
NOTE: Pregnant and breastfeeding women may use it as needed
[DOI] [PMC free article] [PubMed] [Google Scholar] 103.Hu T., Zhang Z., Xu C
P., Hawrelak, J